To cycle or not to cycle: A critical decision in cancer

Nature Reviews Cancer

Volumn 1, Issue 3, 2001, Pages 222-231

  Malumbres, Marcos ^a   Barbacid, Mariano ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CDK2 PROTEIN, HUMAN; CDK2 PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLINE; ENZYME INHIBITOR; PROTEIN SERINE THREONINE KINASE; TUMOR PROTEIN;

ANIMAL; ANIMAL MODEL; BIOLOGICAL MODEL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION; DRUG ANTAGONISM; DRUG DESIGN; ENZYME SPECIFICITY; GENE; GENETICS; HUMAN; MOUSE; MOUSE MUTANT; MUTATION; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; CYCLINS; DRUG DESIGN; ENZYME INHIBITORS; G1 PHASE; GENES, CDC; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; MODELS, BIOLOGICAL; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 0035754080     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/35106065     Document Type: Article

References (21)

1. Norbury, C. & Nurse, P. Animal cell cycles and their control. Annu. Rev. Biochem. 61, 441-470 (1992).
2. Hartwell, L. & Weinert, T. Checkpoints: controls that ensure the order of cell cycle events. Science 246, 629-634 (1989).
3. Morgan, D. O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291 (1997).
4. Sherr, C. J. Cancer cell cycles revisited. Cancer Res. 60, 3689-3695 (2000).
5. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14, 2077-2086 (1994).
6. Jinno, S. et al. Oncogenic stimulation recruits cyclin-dependent kinase in the cell cycle start in rat fibroblast. Proc. Natl Acad. Sci. USA 96, 13197-13202 (1999).
7. Rane, S. G. et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in B-cell hyperplasia. Nature Genet. 22, 44-52 (1999).
8. Tsutsui, T. et al. Targeted disruption of Cdk4 delays cell cycle entry with enhanced p27Kip1 activity. Mol. Cell. Biol. 19, 7011-7019 (1999). References 7 and 8 describe the generation of mice that are deficient for Cdk4. Cdk4 seems to be dispensable for the cell cycle in most cell types. Ablation of Cdk4, however, severely affects proliferation of specific cell types, such as pancreatic β-cells, which leads to diabetes.
9. Ye, X., Zhu, C. & Harper, W. A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. Proc. Natl Acad. Sci. USA 13, 1682-1686 (2001).
10. Nigg, E. A. Cyclin-dependent kinase 7: at the cross-roads of transcription, DNA repair and cell cycle control? Curr. Opin. Cell Biol. 8, 312-317 (1996).
11. 1 cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12, 676-684 (2000).
12. Malumbres, M. & Pellicer, A. Ras pathways to cell cycle control and cell transformation. Front. Biosci. 3, D887-D912 (1998).
13. Diehl, J. A., Cheng, M., Roussel, M. F. & Sherr, C. J. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511 (1998).
14. Alt, J. R., Cleveland, J. L., Hannink, M. & Diehl, J. A. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14, 3102-3114 (2000).
15. Fantl, V., Stamp, G., Andrews, A., Rosewell, I. & Dickson, C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9, 2364-2372 (1995).
16. Sicinski, P. et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621-630 (1995).
17. Sherr, C. J. & Roberts, J. M. Cdk inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999).
18. Adams, P. D. Regulation of the retinoblastoma tumor suppressor protein by cyclin/CDKs. Biochim. Biophys. Acta 1471, 123-133 (2001).
19. Harbour, J. W. & Dean, D. C. The pRb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393-2409 (2000).
20. Morris, E. J. & Dyson, N. J. Retinoblastoma protein partners. Adv. Cancer Res. 82, 1-54 (2001).
21. Lundberg, A. S. & Weinberg, R. A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-CDK complexes. Mol. Cell. Biol. 18, 753-761 (1998).